Stock listing
BOATS:MAZE Maze Therapeutics, Inc. Stock
US listing (BOATS) of Maze Therapeutics, Inc. · home listing NASDAQ:MAZE
Follow Maze Therapeutics, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:MAZE
$32.53 USD -0.85 (-2.5%)
Close on Nov 5, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:MAZE
- Day range
- $31.83 – $33.99 USDNov 5, 2026
- Volume
- 642,926 sharesNov 5, 2026
- Market cap
- $1.81B USDAt the close on Nov 5, 2026 · price × 55.55M shares outstanding
- 52-week range
- $21.95 – $53.65 USDLowest and highest trades, Nov 6, 2025 – Nov 5, 2026
- Traded on an average day
- $18.45M USDMedian day 517,500 shares · last 3 months, Aug 5, 2026 – Nov 5, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:MAZE · Home | $32.53 USD | -0.85 (-2.5%) | 642,926 | $33.43 | $33.99 | $31.83 | $33.38 | Close on Nov 5, 2026 |
Daily closes
Last 3 months, Aug 5, 2026 – Nov 5, 2026 · NASDAQ:MAZE · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $32.53 | -0.85 | -2.5% | $33.43 | $33.99 | $31.83 | 642,926 | |
| $33.38 | +1.13 | +3.5% | $33.00 | $33.59 | $32.10 | 535,740 | |
| $32.25 | +1.88 | +6.2% | $30.80 | $32.48 | $30.14 | 488,818 | |
| $30.37 | -1.11 | -3.5% | $31.70 | $31.70 | $29.76 | 331,179 | |
| $31.48 | -0.45 | -1.4% | $31.93 | $32.19 | $31.23 | 326,504 | |
| $31.93 | +0.20 | +0.6% | $32.17 | $32.63 | $31.56 | 417,914 | |
| $31.73 | +0.04 | +0.1% | $31.24 | $32.04 | $30.89 | 390,821 | |
| $31.69 | +0.62 | +2.0% | $31.18 | $32.01 | $30.88 | 624,985 | |
| $31.07 | +0.06 | +0.2% | $30.93 | $31.67 | $30.71 | 429,412 | |
| $31.01 | -0.94 | -2.9% | $31.86 | $31.86 | $30.54 | 512,900 | |
| $31.95 | -0.63 | -1.9% | $32.45 | $32.95 | $31.71 | 891,100 | |
| $32.58 | +0.13 | +0.4% | $32.52 | $33.19 | $31.56 | 1,068,300 | |
| $32.45 | +2.75 | +9.3% | $29.82 | $32.61 | $29.58 | 1,569,200 | |
| $29.70 | +2.17 | +7.9% | $28.01 | $30.57 | $27.83 | 1,296,000 | |
| $27.53 | +0.05 | +0.2% | $27.50 | $27.89 | $26.72 | 1,018,500 | |
| $27.48 | +1.25 | +4.8% | $26.59 | $28.11 | $26.46 | 540,000 | |
| $26.23 | -0.43 | -1.6% | $26.51 | $27.09 | $25.97 | 835,700 | |
| $26.66 | -1.04 | -3.8% | $27.54 | $28.24 | $26.57 | 615,100 | |
| $27.70 | +0.59 | +2.2% | $27.11 | $29.32 | $26.66 | 1,437,900 | |
| $27.11 | +1.23 | +4.8% | $25.88 | $27.19 | $25.88 | 670,900 | |
| $25.88 | -0.37 | -1.4% | $25.97 | $26.44 | $25.05 | 903,000 | |
| $26.25 | -0.18 | -0.7% | $26.30 | $26.89 | $25.87 | 823,900 | |
| $26.43 | 0.00 | 0.0% | $26.74 | $26.91 | $25.79 | 682,800 | |
| $26.43 | 0.00 | 0.0% | $26.67 | $27.03 | $25.78 | 588,000 | |
| $26.43 | -0.22 | -0.8% | $27.08 | $27.49 | $26.36 | 633,000 | |
| $26.65 | -0.53 | -1.9% | $27.05 | $27.79 | $26.50 | 589,300 | |
| $27.18 | +0.16 | +0.6% | $27.21 | $28.02 | $26.95 | 518,000 | |
| $27.02 | +0.17 | +0.6% | $26.77 | $27.55 | $26.47 | 709,500 | |
| $26.85 | +0.80 | +3.1% | $25.97 | $27.73 | $24.84 | 1,177,300 | |
| $26.05 | -0.16 | -0.6% | $26.23 | $27.79 | $25.42 | 925,600 | |
| $26.21 | -1.88 | -6.7% | $28.42 | $28.46 | $25.96 | 789,200 | |
| $28.09 | -0.29 | -1.0% | $28.30 | $29.91 | $27.53 | 1,704,100 | |
| $28.38 | +5.99 | +26.8% | $24.52 | $29.40 | $24.50 | 3,566,500 | |
| $22.39 | -0.13 | -0.6% | $22.52 | $23.02 | $21.95 | 517,000 | |
| $22.52 | -0.92 | -3.9% | $23.27 | $23.57 | $22.01 | 1,494,800 | |
| $23.44 | -0.475 | -2.0% | $24.38 | $24.80 | $23.27 | 363,500 | |
| $23.92 | -0.315 | -1.3% | $24.33 | $24.72 | $23.74 | 385,700 | |
| $24.23 | -0.44 | -1.8% | $24.63 | $24.80 | $24.00 | 437,400 | |
| $24.67 | +0.07 | +0.3% | $24.90 | $25.85 | $24.46 | 589,300 | |
| $24.60 | -0.22 | -0.9% | $25.14 | $25.99 | $24.36 | 1,052,200 | |
| $24.82 | +0.24 | +1.0% | $24.26 | $25.62 | $23.94 | 1,181,300 | |
| $24.58 | -1.79 | -6.8% | $25.86 | $26.55 | $24.39 | 401,400 | |
| $26.37 | +0.16 | +0.6% | $25.76 | $26.57 | $25.30 | 365,300 | |
| $26.21 | +0.34 | +1.3% | $25.77 | $26.49 | $25.67 | 273,300 | |
| $25.87 | -0.85 | -3.2% | $26.54 | $26.96 | $25.70 | 477,400 | |
| $26.72 | +0.19 | +0.7% | $26.49 | $27.44 | $26.00 | 440,700 | |
| $26.53 | -0.04 | -0.2% | $26.32 | $26.66 | $25.81 | 326,700 | |
| $26.57 | -0.87 | -3.2% | $27.17 | $27.20 | $25.76 | 493,500 | |
| $27.44 | -1.16 | -4.1% | $28.46 | $28.46 | $27.31 | 250,000 | |
| $28.60 | -0.98 | -3.3% | $28.40 | $29.01 | $27.70 | 692,400 | |
| $29.58 | -0.84 | -2.8% | $30.26 | $30.40 | $29.33 | 230,100 | |
| $30.42 | +0.82 | +2.8% | $29.99 | $30.80 | $29.91 | 307,669 | |
| $29.60 | +0.17 | +0.6% | $29.27 | $29.76 | $28.33 | 282,286 | |
| $29.43 | +0.50 | +1.7% | $28.98 | $29.84 | $28.98 | 280,600 | |
| $28.93 | -0.82 | -2.8% | $29.53 | $29.99 | $28.46 | 247,700 | |
| $29.75 | +0.62 | +2.1% | $29.71 | $30.19 | $29.11 | 358,700 | |
| $29.13 | +1.18 | +4.2% | $27.89 | $29.20 | $27.00 | 649,500 | |
| $27.95 | +0.77 | +2.8% | $27.04 | $28.12 | $27.00 | 322,000 | |
| $27.18 | -0.485 | -1.8% | $27.47 | $27.61 | $26.85 | 230,700 | |
| $27.67 | +0.135 | +0.5% | $28.04 | $28.05 | $26.97 | 383,300 | |
| $27.53 | +0.22 | +0.8% | $27.48 | $27.86 | $26.76 | 441,600 | |
| $27.31 | +0.03 | +0.1% | $27.30 | $28.37 | $26.53 | 379,900 | |
| $27.28 | -1.37 | -4.8% | $28.57 | $28.92 | $26.42 | 669,300 | |
| $28.65 | +0.12 | +0.4% | $28.95 | $29.00 | $27.45 | 480,700 | |
| $28.53 | +0.72 | +2.6% | $27.89 | $28.65 | $26.16 | 231,100 | |
| $27.81 | +0.20 | +0.7% | $27.93 | $28.93 | $27.62 | 254,300 |
- Ticker
- BOATS:MAZE
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
What changed lately
Latest news release · Nov 3, 2026
Maze Therapeutics to Participate in Upcoming Investor Conferences
Latest earnings call · Mar 25, 2026
Maze Therapeutics (NASDAQ:MAZE) Q4 2025 Earnings Call
Replay and transcript
Latest deck · Mar 25, 2026
Q4 2025 Earnings Presentation
Earnings · 27 slides
Calls
Replays
Maze Therapeutics (NASDAQ:MAZE) Q4 2025 Earnings Call
Wed, Mar 25, 2026 · 8:00 AM ET
Watch Transcript
Latest news
Maze Therapeutics to Participate in Upcoming Investor Conferences
Nov 3, 2026
Closed $32.25 (+6.2%) on Nov 3, 2026
Maze Therapeutics to Present Data from MZE829 and MZE782 Programs at ASN Kidney Week 2026
Oct 6, 2026
Closed $26.25 (-0.7%) on Oct 7, 2026
Maze Therapeutics to Participate in Three Upcoming Investor Conferences
Sep 2, 2026
Closed $26.72 (+0.7%) on Sep 2, 2026
Maze Therapeutics Announces Appointments to Its Board of Directors
Aug 13, 2026
Closed $27.18 (-1.8%) on Aug 14, 2026
Maze Therapeutics Announces $150 Million Registered Offering
Apr 22, 2026
Closed $26.50 (+3.2%) on Apr 22, 2026
Maze Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Highlights
Mar 25, 2026
Closed $31.73 (-35.2%) on Mar 25, 2026
Maze Therapeutics Announces Positive Topline Data from Phase 2 HORIZON Trial of MZE829 Demonstrating the First Clinical Proof-of-Concept in Patients with Broad APOL1-Mediated Kidney Disease
Mar 25, 2026
Closed $31.73 (-35.2%) on Mar 25, 2026
Maze Therapeutics to Participate in the TD Cowen 46th Annual Health Care Conference
Feb 25, 2026
Closed $47.23 (+4.3%) on Feb 25, 2026
Maze Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
Feb 4, 2026
Closed $48.14 (+0.4%) on Feb 4, 2026
Maze Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
Jan 5, 2026
Closed $38.63 (-2.9%) on Jan 5, 2026
Financings
Private placement of common stock and pre-funded warrants
Sep 11, 2025
Announced: about US$150M · US$16.25 a share · J.P. Morgan +3
Dealers: J.P. Morgan (co-lead), Leerink Partners (co-lead), TD Cowen (co-lead), Guggenheim Securities (co-lead)
Buyers: Frazier Life Sciences; Deep Track Capital; Driehaus Capital Management; Janus Henderson Investors; Logos Capital; TCGX; Venrock Healthcare Capital Partners
Use of proceeds: Advance MZE829 in APOL1-mediated kidney disease, start Phase 2 trials of MZE782 in PKU and CKD, research, Compass platform, working capital
Decks
Q4 2025 Earnings Presentation
Earnings · 27 slides · Mar 25, 2026
Maze Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 10 in the last 12 months · 24 in all · newest Nov 3, 2026 · oldest 2025
- Calls
- 1 call with a replay · 1 with a transcript · latest Mar 25, 2026
- Decks
- 1 deck · latest Mar 25, 2026
Where Maze Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:MAZE · Home listing | NASDAQ | United States | USD |
| BOATS:MAZE · This page | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Maze Therapeutics, Inc.